As ALS patients, caregivers, and families of ALS patients know too well, there are not enough FDA-approved drugs for the treatment of this disease. In fact, there are currently only two pharmaceutical therapies available to patients in the United States: generic riluzole, approved by the FDA in 1995, which modestly extends survival, and Mitsubishi Tanabe […]
ALS Therapy
New Year and New Opportunities for ALS Therapies
December 23, 2021, President Biden signed the Accelerating Access to Critical Therapies for ALS Act, known as ACT for ALS
